Multi-peptide nLC-PC-IDMS-SRM-based Assay for the quantification of biomarkers in the chicken ovarian cancer model

Methods

Volumn 61, Issue 3, 2013, Pages 323-330

  Andrews Kingon, Genna L ^a   Petitte, James N ^a   Muddiman, David C ^a   Hawkridge, Adam M ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Biomarkers; Chicken; Ovarian cancer; Proteomics; Quantification

Indexed keywords

CARRIER PROTEIN; OVOSTATIN; PREALBUMIN; PROTEIN; UNCLASSIFIED DRUG; VITELLOGENIN 1;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; FEMALE; FILTER ASSISTED SAMPLE PREPARATION; GEL ELECTROPHORESIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; TANDEM MASS SPECTROMETRY; TUMOR VOLUME;

ALPHA-MACROGLOBULINS; AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL ASSAY; CALIBRATION; CARBON ISOTOPES; CHICKENS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INDICATOR DILUTION TECHNIQUES; ISOTOPE LABELING; MOLECULAR SEQUENCE DATA; NITROGEN ISOTOPES; OVARIAN NEOPLASMS; PEPTIDE FRAGMENTS; PREALBUMIN; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; VITELLOGENINS;

EID: 84879592194     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2013.04.004     Document Type: Article

References (67)

1. Bast R.C., Hennessy B., Mills G.B. Nat. Rev. Cancer 2009, 9(6):415-428.
2. Williams T.I., et al. J. Proteome Res. 2007, 6(8):2936-2962.
3. Bast R.C., et al. J. Clin. Invest. 1981, 68(5):1331-1337.
4. Bast R.C., et al. N Eng. J. Med. 1983, 309(15):883-887.
5. Xu F.J., et al. J. Clin. Oncol. 1993, 11(8):1506-1510.
6. Menon U., et al. Lancet Oncol. 2009, 10(4):327-340.
7. Molina R., et al. Tumor Biol. 2011, 32(6):1087-1095.
8. Skates S., Knapp R.C. Curr. Prob. Obstetrics, Gynecol., Fertil. 1996, 19(3):85-98.
9. Skates S.J. J. Clin. Ligan Assay 2000, 23(2):150-154.
10. Skates S.J., et al. J. Clin. Oncol. 2003, 21(10 Suppl):206s-210s.
11. Skates S.J., et al. Cancer 1995, 76(10):2004-2010.
12. McIntosh M.W., Urban N. Biostatistics 2003, 4(1):27-40.
13. Williams R.J. Biochemical Individuality: The Basis for the Genetotrophic Concept 1956, John Wiley & Sons, Inc., p. 267.
14. Williams R.J., Brown W.D., Shideler R.W. Proc. Nat. Acad. Sci. USA 1955, 41(9):615-620.
15. Harris E.K. Clin. Chem. 1974, 20(12):1535-1542.
16. Hawkridge A.M., Muddiman D.C. Ann. Rev. Anal. Chem. 2009, 2(1):265-277.
17. Fredrickson T.N. Environ. Health Perspec. 1987, 73:35-51.
18. Barua A., et al. Int. J. Gynecol. Cancer 2009, 19(4):531-539.
19. Carver D.K., et al. Cancer Prevent. Res. 2011, 4(4):562-567.
20. Giles J.R., Olson L.M., Johnson P.A. Exper. Biol. Med. 2006, 231(11):1718-1725.
21. Giles J.R., Shivaprasad H.L., Johnson P.A. Gynecol. Oncol. 2004, 95(3):530-533.
22. Gonzalez Bosquet J., et al. Gynecol. Oncol. 2011, 120(2):256-264.
23. Hakim A.A., et al. Cancer Prevent. Res. 2009, 2(2):114-121.
24. Jackson E., et al. Gynecol. Oncol. 2007, 104(1):192-198.
25. Urick M.E., Giles J.R., Johnson P.A. Gynecol. Oncol. 2009, 112(1):166-170.
26. Urick M.E., Johnson P.A. Gynecol. Oncol. 2006, 103(2):673-678.
27. Fathalla M.F. Lancet 1971, 2(7716):163.
28. Hawkridge A.M., et al. Anal. Bioanal. Chem. 2010, 398(2):737-749.
29. Dixon R.B., et al. Int. J. Mass Spectro. 2011, 305(2-3):79-86.
30. Dass C., Kusmierz J.J., Desiderio D.M. Biol. Mass Spect. 1991, 20(3):130-138.
31. Barr J.R., et al. Clin. Chem. 1996, 42(10):1676-1682.
32. Gerber S.A., et al. Proc. Nat. Acad. Sci. USA 2003, 100(12):6940-6945.
33. Barnidge D.R., et al. J. Proteome Res. 2004, 3(3):658-661.
34. Kuhn E., et al. Proteomics 2004, 4(4):1175-1186.
35. Brun V., et al. J. Proteome Res. 2009, 72(5):740-749.
36. Ciccimaro E., Blair I.A. Bioanalysis 2010, 2(2):311-341.
37. Elschenbroich S., Kislinger T. Mol. Biosys. 2011, 7(2):292-303.
38. Borchers C.H., et al. Mol. Cell. Proteomics 2009, 8(8):1860-1877.
39. Carr S.A., et al. Mol. Cell. Proteomics 2009, 8(10):2339-2349.
40. Carr S.A., et al. Clin. Chem. 2009, 55(6):1108-1117.
41. Kislinger T., et al. J. Proteome Res. 2011, 10(5):2286-2299.
42. Addona T.A., et al. Nature Biotechnol. 2009, 27(7). 633-U85.
43. Wisniewski J.R., et al. Nat. Meth. 2009, 6(5). 359-U60.
44. MacLean B., et al. Bioinformatics 2010, 26(7):966-968.
45. Scopes R.K. Anal. Biochem. 1974, 59(1):277-282.
46. Wisniewski J.R., et al. Nature Meth. 2009, 6(5):359-362.
47. MacLean B., et al. Anal. Chem. 2010, 82(24):10116-10124.
48. Bergen H.R., et al. Disease Markers 2003, 19(4-5):239-249.
49. Salvante K.G., Williams T.D. J. Avian Biol. 2002, 33(4):391-398.
50. Schaller J., et al. Human Blood Plasma Proteins Structure and Function 2008, West Sussex: John Wiley & Sons, Ltd., p. 525.
51. Jacobs D., DeMott W., Oxley D. Jacobs & DeMott Laboratory Test Handbook 1994, Hudson: Lexi-Comp, Inc., p. 1030. fifth ed.
52. Buxbaum J.N., Reixach N. Cell. Mol. Life Sci. 2009, 66(19):3095-3101.
53. Bergen H.R., et al. Clin. Chem. 2004, 50(9):1544-1552.
54. Fung E.T. Clin. Chem. 2010, 56(2):327-329.
55. Collier T.S., et al. Anal. Chem. 2010, 82(20):8696-8702.
56. Old W.M., et al. Mol. Cell. Proteomics 2005, 4(10):1487-1502.
57. Fleming C.E., Nunes A.F., Sousa M.M. Prog. Neurobiol. 2009, 89(3):266-276.
58. Shuford C.M., et al. Mol. Cell. Proteomics 2012, 11(9):814-823.
59. Brownridge P., Beynon R.J. Methods 2011, 54(4):351-360.
60. Nagase H., et al. J. Biol. Chem. 1983, 258(12):7481-7489.
61. Nagase H., Harris E.D. J. Biol. Chem. 1983, 258(12):7490-7498.
62. Saxena I., Tayyab S. Cell. Mol. Life Sci. 1997, 53(1):13-23.
63. Mann K. Proteomics 2007, 7(19):3558-3568.
64. Scherer S.E., et al. Nature 2006, 440(7082):346-351.
65. Lim W., et al. Reprod. Biol. Endocrinol. 2011, 9.
66. Karst A.M., Levanon K., Drapkin R. Proc. Nat. Acad. Sci. USA 2011, 108(18):7547-7552.
67. Kim J., et al. Proc. Nat. Acad. Sci. USA 2012, 109(10):3921-3926.